| Latest Gen Probe News Headlines |
| Date | Time | Source | |
| 08/13/2008 | 4:02PM | PRNUS | FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
- Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems -
SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the US Food and Drug Administration (FDA) has approved its supplemental regulatory... More...>> |
| 07/31/2008 | 4:01PM | PRNUS | Gen-Probe Reports Strong Financial Results for Second Quarter 2008, Raises Full-Year Guidance for Earnings Per Share and Total R
- New Quarterly Record for Product Sales ($113.7 Million, Up 21%) Drives Total Revenues Up 18% Over Prior Year, to $119.8 Million -
SAN DIEGO, Calif., July 31 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) today reported strong financial results for the second quarter of 2008 and raised its full-year... More...>> |
| 07/10/2008 | 6:32PM | PRNUS | Gen-Probe Announces Webcast of Second Quarter 2008 Earnings Conference Call
SAN DIEGO, July 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will release its second quarter 2008 financial results on Thursday, July 31, 2008 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET. Hank... More...>> |
| 07/09/2008 | 8:47AM | PRNUS | Gen-Probe Does Not Intend to Increase Offer to Acquire Innogenetics
SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company does not intend to increase the value of its conditional tender offer to acquire 100% of the outstanding shares, warrants and convertible bonds of Innogenetics (EBR: INNX), a Belgian molecular diagnostics... More...>> |
| 06/16/2008 | 4:05PM | PRNUS | 3M Discontinues Collaboration with Gen-Probe to Develop Molecular Tests for Healthcare-Associated Infections
ST. PAUL, Minn. and SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- 3M and Gen-Probe Incorporated (NASDAQ:GPRO) announced today that 3M has discontinued the companies' collaboration to develop rapid molecular tests for healthcare-associated infections (HCAIs).
The companies, which are exploring the possibility of a future... More...>> |
| 06/16/2008 | 6:30AM | PRNUS | Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference
SAN DIEGO, June 16 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the William Blair & Company 28th Annual Growth Stock on Wednesday, June 18, 2008 at approximately 1:10 p.m. Central Time. The presentation is scheduled to be webcast live and may be accessed... More...>> |
| 06/06/2008 | 4:58PM | PRNUS | Gen-Probe to Webcast Presentation at Seventh Annual Needham Biotechnology and Medical Technology Conference
SAN DIEGO, June 6 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the seventh annual Needham & Company, LLC, Biotechnology and Medical Technology Conference on Wednesday, June 11, 2008 at approximately 11 a.m. Eastern Time (8 a.m. Pacific Time). The presentation... More...>> |
| 06/03/2008 | 5:30PM | PRNUS | Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics
WELLESLEY, Mass., June 3 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, has granted Gen-Probe Incorporated (NASDAQ:GPRO) and its affiliates a non-exclusive license to use Xceed's novel Flow-Thru Chip technology. Gen-Probe expects to incorporate... More...>> |
| 06/03/2008 | 7:39AM | PRNUS | Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
- Acquisition Expected to Accelerate Gen-Probe's Commercial Expansion in Fast-Growing European Market; Add Complementary Products, Technologies and Markers -
SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced... More...>> |
| 05/28/2008 | 4:01PM | PRNUS | Gen-Probe Launches in Europe CE-Marked APTIMA(R) HPV Assay for Detection of Human Papillomavirus
SAN DIEGO, May 28 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company has launched in Europe its APTIMA(R) HPV Assay, a highly specific molecular diagnostic test to detect high-risk strains of the human papillomavirus (HPV), which causes cervical cancer. The APTIMA HPV Assay... More...>> |
| 05/19/2008 | 4:01PM | PRNUS | Lucy Shapiro, Ph.D., Elected to Gen-Probe Board of Directors
SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that Lucy Shapiro, Ph.D., a renowned molecular microbiologist at Stanford University, has been elected to its board of directors. Gen-Probe's board now has eight members, including seven who are not Gen-Probe employees.
"We... More...>> |
| 05/08/2008 | 6:59PM | PRNUS | Gen-Probe to Webcast Two Upcoming Investor Presentations
- Bank of America 2008 Health Care Conference on May 13 -
SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Bank of America 2008 Health Care Conference in Las Vegas on May 13, 2008 at approximately 8 a.m. Pacific time (11 a.m. Eastern... More...>> |
| 04/30/2008 | 6:09PM | PRNUS | Gen-Probe to Webcast Presentation at Deutsche Bank 33rd Annual Health Care Conference
SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Deutsche Bank 33rd Annual Health Care Conference on May 6 at approximately 11:30 a.m. Eastern Time. The presentation is scheduled to be webcast live and may be accessed through a link... More...>> |
| 04/28/2008 | 4:01PM | PRNUS | Gen-Probe Reports Strong Financial Results for First Quarter 2008, Raises Full-Year Guidance
- Company Posts Record Quarterly EPS of $0.58, 45% Above Prior Year, Based on Positive Operating Results and One-Time Legal Benefit -
SAN DIEGO, April 28 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) today reported strong financial results for the first quarter of 2008 and raised its full-year guidance... More...>> |
| 04/24/2008 | 7:26PM | PRNUS | Gen-Probe to Webcast Presentation at Morgan Stanley Global Healthcare Unplugged Conference
SAN DIEGO, April 24 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Morgan Stanley Global Healthcare Unplugged Conference on May 1, 2008 at approximately 4:20 p.m. Eastern Time. The presentation is scheduled to be webcast live and may be accessed through... More...>> |
| 04/10/2008 | 7:55PM | PRNUS | Gen-Probe Announces Webcast of First Quarter 2008 Earnings Conference Call
SAN DIEGO, April 10 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will release its first quarter 2008 financial results on Monday, April 28, 2008 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET. Henry... More...>> |
| 03/31/2008 | 4:02PM | PRNUS | Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company has begun a pivotal U.S. clinical trial of its investigational APTIMA(R) assay to detect human papillomavirus (HPV), which causes cervical cancer.
"Starting this highly complex, multi-center study was... More...>> |
| 03/27/2008 | 4:57PM | PRNUS | Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference
SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Leerink Swann "Bugs and Drugs: The Future of Molecular Diagnostics Roundtable Conference" in New York on April 3, 2008 at approximately 1:20 p.m. Eastern Time. The presentation is... More...>> |
| 03/12/2008 | 4:25PM | PRNUS | Gen-Probe to Webcast Presentations at Lehman and Cowen Healthcare Conferences
SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) announced today that the Company will present at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami Beach on March 18, 2008 at approximately 3:15 p.m. Eastern Time, and at the Cowen and Company 28th Annual Healthcare... More...>> |
| 02/21/2008 | 7:00AM | PRNUS | Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
SAN DIEGO, Feb. 21 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) has submitted to the U.S. Food and Drug Administration (FDA) a supplemental regulatory application for the additional use of the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV), the Company announced... More...>> |